Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection

Authors :: Cooper, David A.
Heera, Jayvant
Goodrich, James
Tawadrous, Margaret
Saag, Michael
De Jesus, Edwin
Clumeck, Nathan
Walmsley, Sharon
Ting, Naitee
Coakley, Eoin
Reeves, Jacqueline D.
Reyes-Teran, Gustavo
Westby, Mike
Van Der Ryst, Elna
Ive, Prudence
Mohapi, Lerato
Mingrone, Horacio
Horban, Andrzej
Hackman, Frances
Sullivan, John
Mayer, Howard
Source :: Journal of Infectious Diseases. March 15, 2010, Vol. 201 Issue 6, p803, 11 p.
Publication Year :: 2010

Subjects :: HIV infection -- Drug therapy
HIV infection -- Patient outcomes
HIV infection -- Research
Maraviroc -- Dosage and administration
Maraviroc -- Research
Efavirenz -- Dosage and administration
Efavirenz -- Research
Drug therapy, Combination -- Patient outcomes
Drug therapy, Combination -- Research
Chemokines -- Physiological aspects
Chemokines -- Genetic aspects
Chemokines -- Research
Health

Tools